Article
Induced pluripotent stem cell-based modeling of hemolytic anemia in patients with compound heterozygous KLF1 mutations reveals defective erythroid differentiation.
Stem cell research & therapy - 11 May 2026
Pratumkaew Ponthip, Wattanapanitch Methichit, Viprakasit Vip, Kheolamai Pakpoom, Issaragrisil Surapol
Abstract excerpt
BACKGROUND: Transfusion-dependent hemolytic anemia caused by compound heterozygosity due to mutations in the erythroid Krüppel-like factor 1 (KLF1) gene is a rare and severe blood disorder. The clinical manifestations of the patient are mainly related to erythroid cells. Moreover, the roles of the identified KLF1 mutations in the pathophysiology of this disease remain unclear due to the lack of an appropriate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
